Adimab
Back to full portfolio
Adimab is an antibody discovery and engineering company. It discovers and engineers therapeutic proteins, from IgGs and HCAbs to multispecifics and TCRs, on a platform built around developability. That focus on developability yields candidates engineered to move from concept to clinic and improve patient outcomes.
FOUNDER(S)
Tillman Gerngross
LEADERSHIP
Tillman Gerngross
Adimab is an antibody discovery and engineering company. It discovers and engineers therapeutic proteins, from IgGs and HCAbs to multispecifics and TCRs, on a platform built around developability. That focus on developability yields candidates engineered to move from concept to clinic and improve patient outcomes.